Long-term results of Tokyo children's cancer study group trials for childhood acute lymphoblastic leukemia, 1984-1999

M. Tsuchida, A. Ohara, A. Manabe, M. Kumagai, H. Shimada, A. Kikuchi, T. Mori, M. Saito, M. Akiyama, T. Fukushima, K. Koike, M. Shiobara, C. Ogawa, T. Kanazawa, Y. Noguchi, S. Oota, Y. Okimoto, H. Yabe, M. Kajiwara, D. TomizawaK. Ko, K. Sugita, T. Kaneko, M. Maeda, T. Inukai, H. Goto, H. Takahashi, K. Isoyama, Y. Hayashi, R. Hosoya, R. Hanada

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

We report the long-term results of Tokyo Children's Cancer Study Group's studies L84-11, L89-12, L92-13, and L95-14 for 1846 children with acute lymphoblastic leukemia, which were conducted between 1984 and 1999. The value of event-free survival (EFS)s.±e. was 67.2±2.2% at 10 years in L84-11, which was not improved in the following two studies, and eventually improved to 75.0±1.8% at 10 years in L95-14 study. The lower EFS of the L89-12 reflected a high rate of induction failure because of infection and delayed remission in very high-risk patients. The L92-13 study was characterized by short maintenance therapy; it resulted in poor EFS, particularly in the standard-risk (SR) group and boys. Females did significantly better than males in EFS in the early three studies. The gender difference was not significant in overall survival, partly because >60% of the males survived after the testicular relapse. Randomized studies in the former three protocols revealed that intermediate-or high-dose methotrexate therapy significantly reduced the testicular relapse rate. In the L95-14 study, gender difference disappeared in EFS. Contrary to the results of larger-scale studies, the randomized control study in the L952-14 reconfirmed with updated data that dexamethasone 8 mg/m2 had no advantage over prednisolone 60 mg/m2 in the SR and intermediate-risk groups. Prophylactic cranial irradiation was assigned to 100, 80, 44, and 44% of the patients in the studies, respectively. Isolated central nervous system relapse rates decreased to <2% in the last two trials. Secondary brain tumors developed in 12 patients at 8-22 years after cranial irradiation. Improvement of the remission induction rates and the complete omission of irradiation are currently main objectives in our studies.

Original languageEnglish
Pages (from-to)383-396
Number of pages14
JournalLeukemia
Volume24
Issue number2
DOIs
Publication statusPublished - 2010 Feb

Keywords

  • Acute lymphoblastic leukemia
  • Children
  • Cranial irradiation
  • Long-term results
  • Secondary malignancy

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Long-term results of Tokyo children's cancer study group trials for childhood acute lymphoblastic leukemia, 1984-1999'. Together they form a unique fingerprint.

  • Cite this

    Tsuchida, M., Ohara, A., Manabe, A., Kumagai, M., Shimada, H., Kikuchi, A., Mori, T., Saito, M., Akiyama, M., Fukushima, T., Koike, K., Shiobara, M., Ogawa, C., Kanazawa, T., Noguchi, Y., Oota, S., Okimoto, Y., Yabe, H., Kajiwara, M., ... Hanada, R. (2010). Long-term results of Tokyo children's cancer study group trials for childhood acute lymphoblastic leukemia, 1984-1999. Leukemia, 24(2), 383-396. https://doi.org/10.1038/leu.2009.260